Solutions > Clinical Registries > Immunology and Rheumatology

Immunology and Rheumatology

Longitudinal, multi-source, curated registries, offering rapid access to deep clinical data, insights and outcomes.

Immunology and Rheumatology Registries


Multiple Sclerosis


Rheumatoid Arthritis


Juvenile Idiopathic Arthritis


Ankylosing Spondylitis


 


Osteoarthritis


Lupus


Other inflammatory


 

  OM1’s Immunology & Rheumatology data reach

Outcomes for RA Patients on Biological DMARDs

  RA patients benefit greatly from the initiation of Biological DMARDs within the first 2 months after start date.

To view outcome scores for individual DMARDs, contact us to get started.

Insights & Outcomes in Near-Real Time

  • Comparative Treatment Benefits
  • Treatment Patterns
  • Therapy Switching
  • Care Pathways
  • Disease Activity
  • Risks of Disease Progression
  • Prescriber Patterns
  • Off-Label Use
  • Dynamics of Use
  • Responders
  • Market Trends
  • Competitive Intelligence

 

Deep Clinical Data

Using cutting-edge technology, OM1 empowers the healthcare industry to access, analyze, and use deeper data in a more robust and clinically meaningful way.

Findings From A Real-World Cohort

AI and Big Data provide a unique opportunity to support clinical development, real-world evidence, value and commercialization strategies. Download this report to learn more about real-world applications.

Get Started